Skip to main content

Articles

Page 15 of 16

  1. In writing the letter to readers of our journal three months ago I was asking about opinions concerning the use of hormone replacement therapy (HRT) in BRCA1/2 carriers after prophylactic adnexectomy, because ...

    Authors: Jan Lubiński
    Citation: Hereditary Cancer in Clinical Practice 2005 3:87
  2. Renal clear cell carcinomas represent about 3% of all visceral cancers and account for approximately 85% of renal cancers in adults. Environmental and genetic factors are involved in the development of renal c...

    Authors: Aleksandra Tołoczko-Grabarek, Andrzej Sikorski, Marek Brzosko and Jan Lubiński
    Citation: Hereditary Cancer in Clinical Practice 2005 3:129
  3. Recently mutations in the MYH gene have been associated with a milder form of adenomatous polyposis which is characterized by a variable level of colonic polyps ranging from a few to several hundred. In the conte...

    Authors: Katie A. Ashton, Cliff J. Meldrum, Mary L. McPhillips, Carla F. Kairupan and Rodney J. Scott
    Citation: Hereditary Cancer in Clinical Practice 2005 3:65
  4. The aim of the study is to evaluate the incidence and phenotype-genotype characteristics of hereditary breast and ovarian cancer syndromes in Latvia in order to develop the basis of clinical management for pat...

    Authors: Andris Gardovskis, Arvids Irmejs, Edvins Miklasevics, Viktors Borosenko, Marianna Bitina, Inga Melbarde-Gorkusa, Andrejs Vanags, Grzegorz Kurzawski, Janina Suchy, Bohdan Górski and Janis Gardovskis
    Citation: Hereditary Cancer in Clinical Practice 2005 3:71
  5. To compare the presentation of invasive breast cancer in BRCA1 and BRCA2 mutation carriers with and without prior bilateral oophorectomy.

    Authors: Kelly A Metcalfe, William D Foulkes, Henry T Lynch, Parviz Ghadirian, Nadine Tung, Ivo A Olivotto, Ellen Warner, Olufunmilayo Olopade, Andrea Eisen, Barbara Weber, Jane McLennan, Ping Sun and Steven A Narod
    Citation: Hereditary Cancer in Clinical Practice 2005 3:53
  6. The NOD2 gene has been associated with susceptibility to Crohn's disease and individuals with Crohn's disease are at increased risk for cancer at a number of organ sites. We studied the association between the...

    Authors: Jan LubiÅ„ski, Tomasz Huzarski, Grzegorz Kurzawski, Janina Suchy, BartÅ‚omiej Masojć, Marek Mierzejewski, Marcin Lener, Wenancjusz DomagaÅ‚a, Maria Chosia, Urszula Teodorczyk, Krzysztof MÄ™drek, Tadeusz DÄ™bniak, Elżbieta ZÅ‚owocka, Jacek Gronwald, Tomasz Byrski, Ewa Grabowska…
    Citation: Hereditary Cancer in Clinical Practice 2005 3:59
  7. Chordoma is a rare mesenchymal tumour of complex biology for which only histologic and immunohistochemical criteria have been defined, but no biomarkers predicting the clinical outcome and response to treatmen...

    Authors: Lidia Larizza, Pietro Mortini and Paola Riva
    Citation: Hereditary Cancer in Clinical Practice 2005 3:29
  8. A substantial minority of individuals who initially apply for genetic counselling for breast/ovarian cancer withdraw at an early stage from the counselling process. This study investigated the self-reported re...

    Authors: Eveline Bleiker, Gea Wigbout, Anja van Rens, Senno Verhoef, Laura van't Veer and Neil Aaronson
    Citation: Hereditary Cancer in Clinical Practice 2005 3:19
  9. The Swedish Family-Cancer Database has been used for almost 10 years in the study of familial risks at all common sites. In the present paper we describe some main features of version VI of this Database, asse...

    Authors: Kari Hemminki, Charlotta Granström and Bowang Chen
    Citation: Hereditary Cancer in Clinical Practice 2005 3:7
  10. The known breast cancer susceptibility genes only account for 20% to 25% of the excess familial risk of the disease [1]. The present study assessed the contribution of BRCA1/2 mutations and CHEK2 variants to the ...

    Authors: Justo Lorenzo Bermejo, Alfonso García Pérez and Kari Hemminki
    Citation: Hereditary Cancer in Clinical Practice 2004 2:185
  11. To determine a cost-efficient strategy for HNPCC molecular diagnostic testing.

    Authors: Francesca Pigatto, Adrian Bateman, David Bunyan, Paul Strike, Esta Wilkins, Claire Curtis, Philippa Duncan, Denzil May, Karen Nugent and Diana Eccles
    Citation: Hereditary Cancer in Clinical Practice 2004 2:175
  12. Multiple Osteochondromas is an autosomal dominant disorder characterised by the presence of multiple osteochondromas and a variety of orthopaedic deformities. Two genes causative of Multiple Osteochondromas, Exos...

    Authors: Liesbeth Hameetman, Judith VMG Bovée, Antonie HM Taminiau, Herman M Kroon and Pancras CW Hogendoorn
    Citation: Hereditary Cancer in Clinical Practice 2004 2:161
  13. To asses the retinal pigment epithelium (RPE) function measured by EOG testing in patients with neurofibromatosis type 1 (NF-1). Our preliminary EOG results suggested dysfunction of the RPE in individuals with...

    Authors: Wojciech Lubiński, Stanisław Zajączek, Zbigniew Sych, Krzysztof Penkala, Olgierd Palacz and Jan Lubiński
    Citation: Hereditary Cancer in Clinical Practice 2004 2:193
  14. To establish the contribution of TP53 germline mutations to familial breast/ovarian cancer in Germany we screened the complete coding region of the TP53 gene in a series of German breast/ovarian cancer families n...

    Authors: Xuan Liu, Hans-Peter Sinn, Hans Ulrich Ulmer, Rodney J Scott and Ute Hamann
    Citation: Hereditary Cancer in Clinical Practice 2004 2:139
  15. Several studies have demonstrated that familial breast cancers associated with BRCA1 or BRCA2 germline mutations differ in their morphological and immunohistochemical characteristics. Cancers associated with BRCA...

    Authors: Emiliano Honrado, Javier Benítez and José Palacios
    Citation: Hereditary Cancer in Clinical Practice 2004 2:131
  16. Prostate cancer is the most common cancer in men and the second highest cause of cancer-related mortality in the U.K. A genetic component in predisposition to prostate cancer has been recognized for decades. O...

    Authors: Sashi Kommu, Stephen Edwards and Rosalind Eeles
    Citation: Hereditary Cancer in Clinical Practice 2004 2:111
  17. Approximately 3-15% of all malignant melanomas (MM) are familial cases. MM is a highly heterogeneous tumour type from a genetic perspective. Pedigrees with disease confined to a single generation of siblings o...

    Authors: Tadeusz Dębniak
    Citation: Hereditary Cancer in Clinical Practice 2004 2:123
  18. We report three Dutch families with familial clustering of (pre)neoplastic cervical disease, review the literature on familial risks of cervical intraepithelial neoplasia (CIN) and cervical cancer, and discuss...

    Authors: Margreet Zoodsma, Rolf H Sijmons, Elisabeth GE de Vries and Ate GJ van der Zee
    Citation: Hereditary Cancer in Clinical Practice 2004 2:99
  19. Approximately 10% of gastric cancer cases show familial clustering but only 1-3% of gastric carcinomas arise as a result of inherited gastric cancer predisposition syndromes. Direct proof that Hereditary Gastr...

    Authors: Carla Oliveira, Gianpaolo Suriano, Paulo Ferreira, Paulo Canedo, Pardeep Kaurah, Rita Mateus, Ana Ferreira, António C Ferreira, Maria José Oliveira, Céu Figueiredo, Fátima Carneiro, Gisela Keller, David Huntsman, José Carlos Machado and Raquel Seruca
    Citation: Hereditary Cancer in Clinical Practice 2004 2:51
  20. Familial adenomatous polyposis (FAP) is characterized by the presence of hundreds to thousands of adenomas that carpet the entire colon and rectum. Nonsense and frameshift mutations in the adenomatous polyposi...

    Authors: Rodney J Scott, Renee Crooks, Lindy Rose, John Attia, Ammarin Thakkinstian, Lesley Thomas, Allan D Spigelman and Cliff J Meldrum
    Citation: Hereditary Cancer in Clinical Practice 2004 2:81
  21. To determine which individuals with colorectal cancer (CRC) were interested in knowing the results of their tumour microsatellite instability (MSI) and immunohistochemistry (IHC) testing. We were also interest...

    Authors: Noralane M Lindor, Jeff Sloan, Richard Goldberg, Deborah Bowen, Sandra Nigon, Amber Roche, Gloria Petersen, Stephen N Thibodeau, Laurence Burgart, Olga Leontovich and Bruce W Morlan
    Citation: Hereditary Cancer in Clinical Practice 2004 2:69
  22. Gastric cancer is the second most frequently diagnosed malignancy worldwide and therefore represents a significant healthcare burden. Environmental and genetic factors are involved in the development of gastri...

    Authors: Beata Gawdis-Wojnarska, Marek Brzosko, Jacek Fliciński, Krzysztof Marlicz, Teresa Starzyńska, Rodney J Scott and Jan Lubiński
    Citation: Hereditary Cancer in Clinical Practice 2004 2:65
  23. Central nervous system hemangioblastomas (cHAB) are rare tumours which most commonly arise in the cerebellum. Most tumours are sporadic, but as many as one third of cHABs occur in the course of the hereditary ...

    Authors: Cezary Cybulski, Joanna Matyjasik, Marianna Soroka, Janusz SzymaÅ›, Bohdan Górski, Tadeusz DÄ™bniak, Anna Jakubowska, Andrzej Bernaczyk, Lech Zimnoch, Grażyna BierzyÅ„ska-Macyszyn, Tomasz Trojanowski, Teresa Wierzba-Bobrowicz, Edmund Prudlak, Alicja Markowska-Wojciechowska, PrzemysÅ‚aw Nowacki, Andrzej Roszkiewicz…
    Citation: Hereditary Cancer in Clinical Practice 2004 2:93
  24. There is much debate in the literature about familial predispositions to breast and bowel cancers yet little evidence is forthcoming to suggest that there are susceptibility genes that can account for such kin...

    Authors: Rodney J Scott and Katie A Ashton
    Citation: Hereditary Cancer in Clinical Practice 2004 2:25
  25. When BRCA1/2 genetic susceptibility testing was introduced in the clinic in the mid-nineties, the "Huntington protocol" was used in the counselling of individuals applying for genetic testing. This protocol inclu...

    Authors: Iris van Oostrom and Aad Tibben
    Citation: Hereditary Cancer in Clinical Practice 2004 2:19
  26. This paper highlights the need for carriers to be followed up by health professionals who understand the complexities of the BRCA syndrome. A BRCA carrier clinic has been established in London and regular follow ...

    Authors: Audrey Ardern-Jones and Rosalind Eeles
    Citation: Hereditary Cancer in Clinical Practice 2004 2:77
  27. The aim of the study is to evaluate the incidence and phenotype - genotype characteristics of hereditary colorectal cancer syndromes in Latvia in order to develop the basis of clinical management for patients ...

    Authors: Arvids Irmejs, Andris Gardovskis, Viktors Borosenko, Marianna Bitina, Diana Aigare, Grzegorz Kurzawski, Janina Suchy, Bohdan Górski and Janis Gardovskis
    Citation: Hereditary Cancer in Clinical Practice 2003 1:49
  28. The criteria for the diagnosis of HNPCC established by the ICG-HNPCC are very restrictive as they do not allow for the diagnosis of a large number of "suspected HNPCC" cases - these are families which do no fu...

    Authors: Józef Kładny, Gabriela Möslein, Torben Myrhøj, Grzegorz Kurzawski, Anna Jakubowska, Tadeusz Dębniak, Wojciech Petriczko, Michał Kozłowski, Tariq Al-Amawi, Marek Brzosko, Jacek Fliciński, Arkadiusz Jawień, Zbigniew Banaszkiewicz, Piotr Rychter and Jan Lubiński
    Citation: Hereditary Cancer in Clinical Practice 2003 1:34
  29. In addition to a relatively small number of well known hereditary cancer syndromes, hundreds of presumed or proven hereditary disorders have been observed to manifest cancer as a characteristic feature or as a...

    Authors: Rolf H. Sijmons and Gerard T.N. Burger
    Citation: Hereditary Cancer in Clinical Practice 2003 1:31

Annual Journal Metrics

  • 2022 Citation Impact
    1.7 - 2-year Impact Factor
    2.2 - 5-year Impact Factor
    0.634 - SNIP (Source Normalized Impact per Paper)
    0.526 - SJR (SCImago Journal Rank)

    2022 Speed
    6 days submission to first editorial decision for all manuscripts (Median)
    148 days submission to accept (Median)

    2022 Usage 
    277,857 downloads
    231 Altmetric mentions